Structure and Function of Fbxo7/PARK15 in Parkinson's Disease
Overview
Authors
Affiliations
Fbxo7/PARK15 has well-defined roles, acting as part of a Skp1-Cul1-F box protein (SCF)- type E3 ubiquitin ligase and also having SCF-independent activities. Mutations within FBXO7 have been found to cause an early-onset Parkinson's disease, and these are found within or near to its functional domains, including its F-box domain (FBD), its proline rich region (PRR), and its ubiquitinlike domain (Ubl). We highlight recent advances in our understanding of Fbxo7 function in Parkinson's disease, with respect to these mutations and where they occur in the Fbxo7 protein. We hypothesize that many of Fbxo7 functions contribute to its role in PD pathogenesis.
Fishman-Jacob T, Youdim M J Neural Transm (Vienna). 2023; 131(6):675-707.
PMID: 37644186 PMC: 11192832. DOI: 10.1007/s00702-023-02687-6.
Zhang H, Zhao Y, Wang J, Li J, Xia J, Lin Y Cell Death Dis. 2023; 14(6):368.
PMID: 37344480 PMC: 10284917. DOI: 10.1038/s41419-023-05891-0.
Zhao S, Wu Y, Wei Y, Xu X, Zheng J Front Immunol. 2022; 13:876616.
PMID: 35799780 PMC: 9254733. DOI: 10.3389/fimmu.2022.876616.
Mitochondrial Neurodegeneration.
Zeviani M, Viscomi C Cells. 2022; 11(4).
PMID: 35203288 PMC: 8870525. DOI: 10.3390/cells11040637.
Mechanisms That Activate 26S Proteasomes and Enhance Protein Degradation.
Goldberg A, Kim H, Lee D, Collins G Biomolecules. 2021; 11(6).
PMID: 34067263 PMC: 8224753. DOI: 10.3390/biom11060779.